Remove 2024 Remove Biotechnology Remove Strategic partnership
article thumbnail

LabVantage Solutions Applauded by Frost & Sullivan for Its Industry-leading Flexible, Scalable, and Cost-effective LIMS Solutions

Frost & Sullivan

October 1, 2024 – Frost & Sullivan assessed the laboratory information management systems (LIMS) industry and, based on its findings, recognizes LabVantage Solutions with the 2024 Global Company of the Year Award. SAN ANTONIO, TX. LabVantage LIMS is an enterprise platform serving the full product life cycle.

article thumbnail

Pharma & Biotech in 2025: The Top 6 Growth Opportunities Shaping the Future

Frost & Sullivan

The pharmaceutical and biotechnology industries are at the cusp of a transformative era in 2025, driven by cutting-edge innovation, evolving regulations, and increasing market pressures. Leading the charge, Novartis Pluvicto has already surpassed blockbuster sales in 2024, highlighting immense investment potential.

Biotech 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmaceutical Outsourcing Evolution: The Rise of Clinical Peripheral Services

Frost & Sullivan

billion in 2024, is projected to grow at a CAGR of 10.7%, reaching $122.13 This article explores the key trends, market drivers, and emerging opportunities in the pharmaceutical clinical contract peripheral services market from 2024 to 2030. The global CRO industry, valued at $66.39 billion by 2030.

article thumbnail

Southern Star Research Applauded by Frost & Sullivan for Delivering Comprehensive Clinical Trial Solutions and Its Competitive Strategies

Frost & Sullivan

13 th February 2025 Frost & Sullivan recently analyzed the biotechnology contract research organization (CRO) industry and, based on its findings, recognizes Southern Star Research with the 2024 Asia-Pacific Competitive Strategy Leadership Award. SAN ANTONIO, TX.

Biotech 52